Nifty, BSE Sensex to Open Higher on Vaccine News

  • Investing.com
  • Stock Market News
Nifty, BSE Sensex to Open Higher on Vaccine News

By Aditya Raghunath

Investing.com -- Just as it seemed that the markets would consolidate on November 10 after six consecutive sessions of rallies, pharma giant Pfizer (NYSE: PFE ) announced that its experimental COVID-19 vaccines tested more than 90% effective. Dow Jones shot up by almost 3% overnight on this news, which means investors can expect Nifty and BSE Sensex to rally strongly today. Nifty Futures are trading up by more than 1% at around 8:45 am.

Pfizer along with its German partner BioNTech has developed the vaccine. They are the first pharmaceutical companies that have released large-scale data from clinical trials of a coronavirus vaccine. The duo has said that they have not found any serious safety issues and will be seeking US approval in November itself to roll out the vaccine for emergency use.

Even though initial trials look promising, it’ll be quite sometime before the vaccine reaches Indian shores. Pfizer says that it can produce up to 50 million doses in 2020 and 1.2 billion doses in 2021. These vaccine doses can only be manufactured after the vaccine is approved.

European stocks ended up at eight-month highs after the vaccine news gave a boost to the rally that was already going on after Joe Biden was announced as the President-elect of the USA. The FTSE gained 4.67%, CAC was up 7.57% and the DAC ended 4.94% higher. Japan’s Nikkei 225 is trading 1.31% higher in early trade. Australia’s ASX Ltd (ASX: ASX ) 200 was up 1.54%. South Korea’s KOSPI was also up 0.22% after dropping early.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles